The ctDNA-RECIST Trial Part One
NCT06562348
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
167
Enrollment
OTHER
Sponsor class
Conditions
Gastrointestinal Neoplasm
Interventions
OTHER:
Standard of care
OTHER:
ctDNA-RECIST guided palliative systemic treatment
Sponsor
Karen-Lise Garm Spindler
Collaborators
[object Object]